Personal Cfo Solutions, LLC Novo Nordisk A S Transaction History

Personal Cfo Solutions, LLC

$636 Million
Q2 2024

A detailed history of Personal Cfo Solutions, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 30,787 shares of NVO stock, worth $3.59 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

30,787

Previous 29,880 3.04%

Holding current value

$3.59 Million

Previous $3.84 Million 14.55%

% of portfolio

0.69%

Previous 0.64%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $111,297 - $133,247	907 Added 3.04%	30,787 $4.39 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $10,823 - $14,407	106 Added 0.36%	29,880 $3.84 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $6,495 - $7,803	-74 Reduced 0.25%	29,774 $3.08 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $1.56 Million - $3.42 Million	17,119 Added 134.49%	29,848 $2.71 Million
Q2 2023 Aug 10, 2023	SELL	$155.98 - $172.65 $5,147 - $5,697	-33 Reduced 0.26%	12,729 $2.06 Million
Q1 2023 May 09, 2023	SELL	$132.34 - $159.14 $27,394 - $32,941	-207 Reduced 1.6%	12,762 $2.03 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $17,023 - $22,464	-166 Reduced 1.26%	12,969 $1.76 Million
Q3 2022 Nov 01, 2022	SELL	$95.28 - $116.93 $46,591 - $57,178	-489 Reduced 3.59%	13,135 $1.31 Million
Q2 2022 Aug 05, 2022	BUY	$103.24 - $121.81 $176,333 - $208,051	1,708 Added 14.33%	13,624 $1.52 Million
Q1 2022 May 02, 2022	BUY	$93.1 - $112.54 $733,255 - $886,365	7,876 Added 194.95%	11,916 $1.32 Million
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $1,725 - $2,107	18 Added 0.45%	4,040 $452,000
Q3 2021 Nov 18, 2021	BUY	$84.42 - $106.62 $339,537 - $428,825	4,022 New	4,022 $386,000
Q1 2021 Apr 21, 2021	SELL	$67.06 - $75.82 $295,533 - $334,138	-4,407 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $12,650 - $14,612	198 Added 4.7%	4,407 $307,000
Q3 2020 Nov 02, 2020	BUY	$63.69 - $70.22 $13,247 - $14,605	208 Added 5.2%	4,209 $0
Q2 2020 Aug 03, 2020	BUY	$58.54 - $67.94 $15,513 - $18,004	265 Added 7.09%	4,001 $262,000
Q1 2020 Apr 30, 2020	SELL	$49.46 - $64.78 $22,009 - $28,827	-445 Reduced 10.64%	3,736 $225,000
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $208,464 - $243,585	4,181 New	4,181 $242,000

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $263B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account

Personal Cfo Solutions, LLC Novo Nordisk A S Transaction History